How many new prescriptions for Zepbound will be issued by end of 2025? | Categorical | | | 1 day ago | |
How many Zepbound prescriptions will be filled in Q1 2025? | Categorical | | | 2 days ago | |
Will U.S. adult obesity rate decrease by more than 1% in 2025? | Binary | | | 9 days ago | |
Will Zepbound receive FDA approval for another indication by end of 2025? | Binary | | | 20 days ago | |
Will Zepbound receive expanded insurance coverage for sleep apnea by June 30, 2025? | Binary | | | 20 days ago | |
Will FDA approve a generic tirzepatide by end of 2025? | Binary | | | 21 days ago | |
Will Zepbound receive EMA approval by the end of 2025? | Binary | | | 21 days ago | |
Semaglutide removed from FDA drug shortage list by June 30, 2024? | Binary | | | 22 days ago | |
Will Zepbound price drop by 20% or more by June 30, 2025? | Binary | | | 1 month ago | |
Will FDA issue warning or ban on compounded GLP-1 drugs by end of 2025? | Binary | | | 1 month ago | |
Will the FDA approve Zepbound for an expanded indication by end of 2025? | Binary | | | 1 month ago | |
Will Novo Nordisk announce a new clinical trial to compete with Zepbound by June 2025? | Binary | | | 1 month ago | |
Will $LLY stock rise by more than 20% by end of 2025 due to Zepbound's Medicare coverage? | Binary | | | 1 day ago | |
Will Zepbound achieve $500M in sales in its first year of Medicare coverage? | Binary | | | 2 days ago | |
Will a major insurer cover Zepbound for OSA by mid-2025? | Binary | | | 2 days ago | |
Will Brazil distribute generic Ozempic in public clinics by June 2025? | Binary | | | 9 days ago | |
What new treatment application will Novo Nordisk or Eli Lilly announce for weight-loss drugs by end of 2025? | Categorical | | | 9 days ago | |
How many new sleep apnea medications will the FDA approve in 2025? | Categorical | | | 20 days ago | |
Will Zepbound sales exceed $500 million by end of 2025? | Binary | | | 20 days ago | |
Will the FDA issue new guidelines for compounding pharmacies on obesity drugs by December 31, 2025? | Binary | | | 20 days ago | |
Will Eli Lilly's stock price increase by 10% or more by March 31, 2025? | Binary | | | 20 days ago | |
Will Zepbound be prescribed to over 1 million patients for sleep apnea by 2024? | Binary | | | 21 days ago | |
What will be the first year sales of Zepbound in the US? | Categorical | | | 21 days ago | |
Will Zepbound achieve $500 million in sales by the end of 2025? | Binary | | | 21 days ago | |
FDA enforcement against 503(b) compounders for tirzepatide by March 31, 2024? | Binary | | | 22 days ago | |
FDA enforcement against 503(a) compounders for tirzepatide by February 29, 2024? | Binary | | | 22 days ago | |
Will Ro-Lilly partnership boost Zepbound prescriptions by 50% by end of 2025? | Binary | | | 1 month ago | |
Hims & Hers Health, Inc. stock recovers to pre-announcement level by Q1 2025? | Binary | | | 1 month ago | |
What market share will Zepbound achieve in US weight-loss market by end of 2025? | Categorical | | | 1 month ago | |
Will Zepbound become the leading weight-loss drug by US market share by end of 2025? | Binary | | | 1 month ago | |
Will Zepbound receive FDA approval for expanded obesity treatment use by end of 2025? | Binary | | | 1 month ago | |
Will Zepbound be the leading obesity drug by market share in the US by end of 2025? | Binary | | | 1 month ago | |
Which drug will be the leading obesity drug by global sales in 2025? | Categorical | | | 1 month ago | |
Which major pharmaceutical company will announce a competing obesity drug trial by end of 2025? | Categorical | | | 1 month ago | |
Will Eli Lilly's stock price increase by 10% or more by March 2025 following Zepbound trial results? | Binary | | | 1 month ago | |
What will be the leading treatment for moderate-to-severe OSA by market share by end of 2025? | Categorical | | | 1 day ago | |
Will Zepbound face significant backlash or legal challenges due to cost by end of 2025? | Binary | | | 1 day ago | |
What will be the total revenue from Zepbound under Medicare Part D by end of 2025? | Categorical | | | 1 day ago | |
Will Zepbound be the leading OSA treatment by prescription volume in the US by end of 2025? | Binary | | | 1 day ago | |
Will Zepbound receive additional FDA approvals by the end of 2025? | Binary | | | 2 days ago | |
How much will Zepbound affect Eli Lilly's stock price by end of 2025? | Categorical | | | 2 days ago | |
What will be Zepbound's market share in sleep apnea treatments by end of 2025? | Categorical | | | 2 days ago | |
What will be the primary barrier to weight-loss drug adoption in the U.S. by end of 2025? | Categorical | | | 9 days ago | |
Will U.S. grocery spending decrease by an additional 2% in 2025? | Binary | | | 9 days ago | |
Will over 75% of U.S. health insurance plans cover Zepbound by end of 2024? | Binary | | | 20 days ago | |
What will be Eli Lilly's revenue from Zepbound in 2025? | Categorical | | | 20 days ago | |
What will be the percentage reduction in apnea-hypopnea index for Zepbound users by end of 2025? | Categorical | | | 20 days ago | |
Will Zepbound be approved for sleep apnea in the EU by mid-2025? | Binary | | | 20 days ago | |
How many new competitors will enter the sleep apnea treatment market by end of 2025? | Categorical | | | 20 days ago | |
What will be the average symptom reduction for Zepbound patients by end of 2025? | Categorical | | | 20 days ago | |
Which treatment will hold the largest market share for sleep apnea by end of 2025? | Categorical | | | 20 days ago | |
Will Zepbound be the leading sleep apnea treatment by market share by end of 2025? | Binary | | | 20 days ago | |
Impact of Zepbound on sleep apnea treatment costs by December 31, 2025 | Categorical | | | 20 days ago | |
Market share changes among obesity drug manufacturers by December 31, 2025 | Categorical | | | 20 days ago | |
Number of new Zepbound prescriptions for sleep apnea by June 30, 2025 | Categorical | | | 20 days ago | |
Will Zepbound receive expanded insurance coverage by mid-2025? | Binary | | | 21 days ago | |
Next country to approve Zepbound for sleep apnea after U.S.? | Categorical | | | 21 days ago | |
Percentage of Zepbound users symptom-free after one year by 2025? | Categorical | | | 21 days ago | |
Primary competitor to Zepbound in sleep apnea treatment by 2025? | Categorical | | | 21 days ago | |
Will Zepbound achieve over 60% market share in sleep apnea drugs by 2025? | Binary | | | 21 days ago | |
First major pharma company to announce Zepbound competitor by end of 2025? | Categorical | | | 21 days ago | |
Percentage of Zepbound users symptom-free after one year by end of 2025? | Categorical | | | 21 days ago | |
Region with highest Zepbound adoption by mid-2025? | Categorical | | | 21 days ago | |
Will Zepbound achieve over 50% market share in sleep apnea treatments by end of 2025? | Binary | | | 20 days ago | |
Will any major insurance provider cover Zepbound by March 31, 2025? | Binary | | | 21 days ago | |
Will a major insurance provider cover Zepbound by mid-2025? | Binary | | | 21 days ago | |
What will be Zepbound's market share in OSA treatment by end of 2025? | Categorical | | | 21 days ago | |
In how many countries will Zepbound be approved by end of 2025? | Categorical | | | 21 days ago | |
Primary reason for next FDA drug shortage announcement in 2025? | Categorical | | | 22 days ago | |
Next company after Eli Lilly with FDA drug shortage resolution by December 31, 2024? | Categorical | | | 22 days ago | |
Next drug removed from FDA shortage list in 2025? | Categorical | | | 22 days ago | |
How many new partnerships will Eli Lilly form for Zepbound by end of 2025? | Categorical | | | 1 month ago | |
What will be the market share change between Zepbound and Wegovy by end of 2025? | Categorical | | | 1 month ago | |
Leader in GLP-1 weight-loss drug market by end of 2025? | Categorical | | | 1 month ago | |
Ro faces legal challenges over Zepbound distribution by end of 2024? | Binary | | | 1 month ago | |
Eli Lilly's Zepbound sales increase by more than 20% in Q1 2025? | Binary | | | 1 month ago | |
Impact of Ro's partnership with Eli Lilly on customer base by mid-2025? | Categorical | | | 1 month ago | |
Eli Lilly's Zepbound market share in weight-loss drugs by end of 2025? | Categorical | | | 1 month ago | |
In how many countries will Zepbound be approved for obesity treatment by end of 2025? | Categorical | | | 1 month ago | |
What will be the average weight loss percentage in a new Zepbound trial by end of 2025? | Categorical | | | 1 month ago | |
Will Novo Nordisk announce a Wegovy successor trial with improved efficacy by end of 2024? | Binary | | | 1 month ago | |
Which regulatory body will approve Zepbound next after the FDA by end of 2025? | Categorical | | | 1 month ago | |
Will Eli Lilly stock outperform Novo Nordisk stock in 2025? | Binary | | | 1 month ago | |
What will be the market share distribution between Eli Lilly and Novo Nordisk in obesity drugs by end of 2025? | Categorical | | | 1 month ago | |
Will Zepbound receive FDA approval for obesity treatment by end of 2025? | Binary | | | 1 month ago | |
Which major pharmaceutical company will announce the next competitive obesity treatment by end of 2025? | Categorical | | | 1 month ago | |
Which region will grant the next major regulatory approval for Zepbound by end of 2025? | Categorical | | | 1 month ago | |
Which U.S. economic sector will weight-loss drugs impact most by end of 2025? | Categorical | | | 9 days ago | |
How will public opinion on GLP-1 drug affordability change by end of 2025? | Categorical | | | 1 month ago | |